ICUI — ICU Medical Inc. stock price and chart

Share this page

ICUI

$162.99-2.54%

as of close, Oct 16, 2026

☾ AH $162.99 -2.54%

ICU Medical Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.005%Russell 3000 0.005%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

100.0120.0140.0160.0180.0200.0220.0240.0260.0280.0300.005.0M$162.99

2026-10-16

Price$162.99

MA20$153.84

MA50$142.42

Vol1.3M

What would $1,000 invested in ICUI be worth today? →

ICUI returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $162.99
YTD price return: +14.24%
YTD total return: +14.24%
Next earnings: Nov 5, 2026
Market cap: 4.1B2016-12 2.4B2026-10 4.1B+69.4% over the window
Enterprise value: 5.1B
Shares outstanding: 25M2016-06 16.1M2026-06 25M+55.0% over the window
52W low: $113.37
52W high: $192.85
From 52W high: -15.48%
From 52W low: +43.77%
52W range: 62%

Volume

Rel volume: 0.91×
30D volume: 243.1K
30D $ vol: 39M

Fundamentals

Sales (ttm): 2.2B2016-06 363M2026-06 2.2B+495.0% over the window
Sales/share: $86.362016-06 $22.502026-06 $86.36+283.8% over the window
EPS (ttm): $1.202016-06 $3.372026-06 $1.20-64.3% over the window
FCF (ttm): 152.8M2016-06 59.7M2026-06 152.8M+156.0% over the window
FCF/share: $6.112016-06 $3.702026-06 $6.11+65.1% over the window
Book value/share: $86.052016-06 $38.202026-06 $86.05+125.3% over the window
Net margin: 1.39%2016-06 15.6%2026-06 1.4%-91.0% over the window
ROE: 1.40%2016-06 9.2%2026-06 1.4%-84.7% over the window
ROA: 0.76%2016-06 8.5%2026-06 0.8%-91.1% over the window
Debt / equity: 0.56×2016-12 0.002026-06 0.56
Current ratio: 2.432016-06 13.182026-06 2.43-81.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: -8.98%2025-06-30 → 2026-06-302.4B → 2.2B (-9.0% total)-1.99%2023-06-30 → 2026-06-302.3B → 2.2B (-5.9% total)+10.80%2021-03-31 → 2026-06-301.3B → 2.2B (+71.3% total)+19.53%2016-06-30 → 2026-06-30363M → 2.2B (+495.0% total)
Net income: n/an/a-19.47%2021-03-31 → 2026-06-3093.8M → 30.1M (-67.9% total)-6.11%2016-06-30 → 2026-06-3056.5M → 30.1M (-46.7% total)
FCF: +152.69%2025-06-30 → 2026-06-3060.5M → 152.8M (+152.5% total)n/a-0.14%2021-03-31 → 2026-06-30154M → 152.8M (-0.7% total)+9.86%2016-06-30 → 2026-06-3059.7M → 152.8M (+156.0% total)
Shares: +1.30%2025-06-30 → 2026-06-3024.7M → 25M (+1.3% total)+1.19%2023-06-30 → 2026-06-3024.1M → 25M (+3.6% total)+3.18%2021-03-31 → 2026-06-3021.2M → 25M (+17.9% total)+4.48%2016-06-30 → 2026-06-3016.1M → 25M (+55.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: n/an/a-21.71%2021-03-31 → 2026-06-30$4.34 → $1.20 (-72.3% total)-9.80%2016-06-30 → 2026-06-30$3.37 → $1.20 (-64.3% total)
Sales/share: -10.15%2025-06-30 → 2026-06-30$96.11 → $86.36 (-10.1% total)-3.14%2023-06-30 → 2026-06-30$95.04 → $86.36 (-9.1% total)+7.39%2021-03-31 → 2026-06-30$59.40 → $86.36 (+45.4% total)+14.40%2016-06-30 → 2026-06-30$22.50 → $86.36 (+283.8% total)
FCF/share: +149.44%2025-06-30 → 2026-06-30$2.45 → $6.11 (+149.3% total)n/a-3.22%2021-03-31 → 2026-06-30$7.26 → $6.11 (-15.8% total)+5.14%2016-06-30 → 2026-06-30$3.70 → $6.11 (+65.1% total)
Book value/share: +0.40%2025-06-30 → 2026-06-30$85.71 → $86.05 (+0.4% total)-0.60%2023-06-30 → 2026-06-30$87.62 → $86.05 (-1.8% total)+3.55%2021-03-31 → 2026-06-30$71.67 → $86.05 (+20.1% total)+8.46%2016-06-30 → 2026-06-30$38.20 → $86.05 (+125.3% total)
Price: +39.95%2025-10-16 → 2026-10-16$116.49 → $162.99 (+39.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.65%2023-10-16 → 2026-10-16$111.02 → $162.99 (+46.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-6.72%2021-10-15 → 2026-10-16$230.84 → $162.99 (-29.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.02%2016-10-14 → 2026-10-16$147.20 → $162.99 (+10.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +39.95%2025-10-16 → 2026-10-16$116.49 → $162.99 (+39.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.65%2023-10-16 → 2026-10-16$111.02 → $162.99 (+46.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.72%2021-10-15 → 2026-10-16$230.84 → $162.99 (-29.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.02%2016-10-14 → 2026-10-16$147.20 → $162.99 (+10.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 135.7×2016-12 40.762026-10 135.45+232.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 56.6×2016-12 29.462026-10 56.56+92.0% over the window
Fwd P/E: 16.6×
P/S (ttm)Market cap ÷ TTM revenue.: 1.9×2016-12 6.432026-10 1.89-70.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.9×2016-12 3.712026-10 1.89-49.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 26.7×2016-12 37.602026-10 26.67-29.1% over the window
EV/EBITDA (fy): 18.5×
EV/Sales (ttm): 2.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.75%2016-09 2.7%2026-06 4.2%+56.7% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 25.0M ÷ 24.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.30%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.30%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($3.3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.30%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($8.8M) ÷ today's market cap ($4.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.22%2016-09 0.7%2026-06 0.2%-66.5% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $8.8M + TTM dividends $0) ÷ today's market cap ($4.1B). Same caveat as the cash buyback yield.: 0.22%2016-09 0.7%2026-06 0.2%-66.5% over the window

Vs own 10Y history

P/E: 85th
P/OI: 49th
P/S: 36th
P/B: 31st
P/FCF: 15th

Bar = where today’s multiple sits in ICUI’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.54%

+1.67%

+4.74%

+0.51%

YTD

+14.24%

+39.92%

-29.39%

Financial statements

Open full ICUI financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

ICUI — ICU Medical Inc. price, chart and key statistics